Moleculin Biotech(DE:MOL)
€7.580.00 (0.00%)
DE:MOL
Moleculin Biotech earnings date
€7.58
At close:0.00 (0.00%)
Moleculin Biotech (MOL) Q4 2023 Earnings Report
3 Followers
DE:MOL Q4 2023 EPS Results
- Actual EPS
- -EUR 2,247.33
- Consensus EPS
- -EUR 1,443.75
- Beat/Miss
- Missed by -EUR 803.58
- One Year Ago EPS
- -EUR 1,544.48
DE:MOL Q4 2023 Revenue Results
- Actual Revenue
- EUR 0
- Expected Revenue
- EUR 0
- Beat/Miss
- Met expectations
- YoY Revenue Growth
- ―
Earnings Announcement Details
- Quarter
- Q4 2023
- Date
- 03/22/2024
- Time
- After Close
- Conference Call
- Friday, March 22, 2024
DE:MOL Upcoming Earnings
Moleculin Biotech's next earnings date is estimated for March 19, 2027, based on past reporting schedules.
Q4 2023 Earnings Call Audio
DE:MOL Q4 2023 Earnings Call
0:00 / 0:00
Q4 2023 Earnings Slide Deck
No slide deck is available for this earnings event.
Q4 2023 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:MOL Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Mar 19, 2027 | 2026 (Q4) | ―- | 2.34 | ― | ― |
| Aug 14, 2026 | 2026 (Q2) | -27.82-25.07 | -219.36 | 88.57% (+194.29) | |
| May 15, 2026 | 2026 (Q1) | -41.78-63.39 | -308.9 | 79.48% (+245.50) | |
| Mar 19, 2026 | 2025 (Q4) | -109.4746.74 | 111.92 | -58.24% (-65.18) | |
| Nov 17, 2025 | 2025 (Q3) | -5.89-15.23 | -63.79 | 76.12% (+48.56) | |
| Aug 13, 2025 | 2025 (Q2) | -192.50-219.36 | -761.05 | 71.18% (+541.69) | |
| May 14, 2025 | 2025 (Q1) | -248.46-308.90 | -904.3 | 65.84% (+595.41) | |
| Mar 24, 2025 | 2024 (Q4) | -574.52111.92 | -2247.33 | 104.98% (+2359.25) | |
| Nov 11, 2024 | 2024 (Q3) | -1092.33-1275.87 | -1275.87 | 0.00% (+0.00) | |
| Aug 14, 2024 | 2024 (Q2) | -1123.66-761.05 | -1343.02 | 43.33% (+581.98) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
